365
Participants
Start Date
August 2, 2024
Primary Completion Date
May 1, 2028
Study Completion Date
May 1, 2029
PF-08052666
Given into the vein (IV; intravenously)
RECRUITING
Atrium Health Wake Forest Baptist, Department of Pharmacy, Investigational Drug Service, Winston-Salem
RECRUITING
Atrium Health Wake Forest Baptist, Winston-Salem
RECRUITING
Mayo Clinic Pharmacy, Jacksonville
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
The University of Alabama at Birmingham, Birmingham
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Sarah Cannon Research Institute - Pharmacy, Nashville
RECRUITING
SCRI Oncology Partners, Nashville
RECRUITING
Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Hilliard
RECRUITING
James Cancer Hospital and Solove Research Institute, Columbus
RECRUITING
Ohio State University Hospital, Columbus
RECRUITING
OSU Brain and Spine Hospital, Columbus
RECRUITING
Martha Morehouse Tower, Columbus
RECRUITING
Mayo Clinic, Rochester
RECRUITING
The University of Kansas Hospital Cambridge North Tower A, Kansas City
RECRUITING
The University of Kansas Hospital, Kansas City
RECRUITING
The University of Kansas Medical Center Medical Office Building, Kansas City
RECRUITING
The University of Kansas Medical Center Research Institute, Inc, Kansas City
RECRUITING
The University of Kansas Clinical Research Center, Fairway
RECRUITING
The University of Kansas Cancer Center - Westwood, Westwood
RECRUITING
The University of Kansas Cancer Center, Investigational Drug Services, Westwood
RECRUITING
The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
RECRUITING
START San Antonio, LLC, San Antonio
RECRUITING
START Mountain Region, West Valley City
RECRUITING
Mayo Clinic Hospital, Phoenix
RECRUITING
Mayo Clinic, Scottsdale
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
University Health Network, Toronto
RECRUITING
University Health Network, Princess Margaret Cancer Centre, Toronto
RECRUITING
The Research Institute of the McGill University Health Centre, Montreal
RECRUITING
McGill University Health Centre, Montreal
Seagen, a wholly owned subsidiary of Pfizer
INDUSTRY